Sequana Medical NV announced that at its Special General Meeting of Shareholders held on June 26, 2023, approved the appointment of Dr. Kenneth Macleod as non-executive director of the Company. Dr. Kenneth Macleod is a Partner at Rosetta Capital. Dr. Macleod has over 35 years' experience in the life sciences sector in a career combining senior operating roles in healthcare companies (Abbott Laboratories, Serono SA) and life science fund management (SV Health Investors, Paul Capital Partners, Visium Healthcare Partners).

Dr. Macleod currently holds board positions at JenaValve Technology Inc. and Oxular Limited and has previously held board roles including at Pharming Group N.V. and On-X Life Technologies Inc. Dr. Macleod received a BSc in Biological Sciences from the University of Manchester and a D.Phil. from the University of York.